Literature DB >> 28139678

Cocaine Potency at the Dopamine Transporter Tracks Discrete Motivational States During Cocaine Self-Administration.

Cody A Siciliano1, Sara R Jones1.   

Abstract

Although the dopamine transporter (DAT) is the primary site of action for cocaine, and the dopamine system is known to mediate the reinforcing effects of cocaine, the dopaminergic variations underlying individual differences in cocaine self-administration behaviors are not fully understood. Recent advances in the application of economic principles to operant tasks in rodents have allowed for the within-subject, within-session determination of both consummatory and appetitive responding for reinforcers. Here we combined a behavioral economics approach with cocaine self-administration and ex vivo voltammetric recording of dopamine signaling in the core of the nucleus accumbens of rats to determine the relationship between dopamine signaling and discrete aspects of cocaine taking and seeking. We found neither dopamine release or uptake tracked individual differences in cocaine consumption or the reinforcing efficacy of cocaine. Cocaine potency at the DAT was correlated with reinforcing efficacy, but was not related to cocaine consumption. Further, we introduce a novel analysis that determines perseverative responding within the same procedure, and find that cocaine potency at the DAT also tracks differences in perseverative responding. Together, we demonstrate that cocaine effects at the DAT determine the reinforcing efficacy of cocaine, and perseverative responding for sub-threshold doses of cocaine that do not maintain responding when presented in isolation. Surprisingly, we find that variations in cocaine potency do not account for differences in cocaine consumption, suggesting that satiation for cocaine is determined by other targets or mechanisms. Finally, we outline a novel approach for relating drug-target interactions and potency to discrete motivational states during a single self-administration session.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28139678      PMCID: PMC5520781          DOI: 10.1038/npp.2017.24

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  66 in total

1.  Satiety threshold: a quantitative model of maintained cocaine self-administration.

Authors:  V L Tsibulsky; A B Norman
Journal:  Brain Res       Date:  1999-08-21       Impact factor: 3.252

2.  Intermittent cocaine self-administration produces sensitization of stimulant effects at the dopamine transporter.

Authors:  Erin S Calipari; Mark J Ferris; Cody A Siciliano; Benjamin A Zimmer; Sara R Jones
Journal:  J Pharmacol Exp Ther       Date:  2014-02-24       Impact factor: 4.030

3.  Contrasting forms of cocaine-evoked plasticity control components of relapse.

Authors:  Vincent Pascoli; Jean Terrier; Julie Espallergues; Emmanuel Valjent; Eoin Cornelius O'Connor; Christian Lüscher
Journal:  Nature       Date:  2014-05-22       Impact factor: 49.962

4.  Less is more: prolonged intermittent access cocaine self-administration produces incentive-sensitization and addiction-like behavior.

Authors:  Alex B Kawa; Brandon S Bentzley; Terry E Robinson
Journal:  Psychopharmacology (Berl)       Date:  2016-08-02       Impact factor: 4.530

5.  Competitive dopamine receptor antagonists increase the equiactive cocaine concentration during self-administration.

Authors:  Andrew B Norman; Mantana K Norman; Michael R Tabet; Vladimir L Tsibulsky; Amadeo J Pesce
Journal:  Synapse       Date:  2010-10-08       Impact factor: 2.562

6.  Cocaine self-administration in rats: threshold procedures.

Authors:  Erik B Oleson; David C S Roberts
Journal:  Methods Mol Biol       Date:  2012

7.  Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations.

Authors:  Xiaoqin Huang; Howard H Gu; Chang-Guo Zhan
Journal:  J Phys Chem B       Date:  2009-11-12       Impact factor: 2.991

8.  Brief intermittent cocaine self-administration and abstinence sensitizes cocaine effects on the dopamine transporter and increases drug seeking.

Authors:  Erin S Calipari; Cody A Siciliano; Benjamin A Zimmer; Sara R Jones
Journal:  Neuropsychopharmacology       Date:  2014-09-12       Impact factor: 7.853

9.  Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction.

Authors:  Andre Hermans; Richard B Keithley; Justin M Kita; Leslie A Sombers; R Mark Wightman
Journal:  Anal Chem       Date:  2008-04-24       Impact factor: 6.986

10.  Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration.

Authors:  Garret D Stuber; Mitchell F Roitman; Paul E M Phillips; Regina M Carelli; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2005-05       Impact factor: 7.853

View more
  15 in total

1.  Susceptibility to traumatic stress sensitizes the dopaminergic response to cocaine and increases motivation for cocaine.

Authors:  Zachary D Brodnik; Emily M Black; Meagan J Clark; Kristen N Kornsey; Nathaniel W Snyder; Rodrigo A España
Journal:  Neuropharmacology       Date:  2017-08-01       Impact factor: 5.250

2.  High and escalating levels of cocaine intake are dissociable from subsequent incentive motivation for the drug in rats.

Authors:  Florence Allain; Karim Bouayad-Gervais; Anne-Noël Samaha
Journal:  Psychopharmacology (Berl)       Date:  2017-10-31       Impact factor: 4.530

3.  Granulocyte Colony Stimulating Factor Enhances Reward Learning through Potentiation of Mesolimbic Dopamine System Function.

Authors:  Munir Gunes Kutlu; Lillian J Brady; Emily G Peck; Rebecca S Hofford; Jordan T Yorgason; Cody A Siciliano; Drew D Kiraly; Erin S Calipari
Journal:  J Neurosci       Date:  2018-08-27       Impact factor: 6.167

4.  Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.

Authors:  Zachary D Brodnik; Wei Xu; Aashita Batra; Stacia I Lewandowski; Christina M Ruiz; Ole V Mortensen; Sandhya Kortagere; Stephen V Mahler; Rodrigo A España
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

5.  Synaptic Microtubule-Associated Protein EB3 and SRC Phosphorylation Mediate Structural and Behavioral Adaptations During Withdrawal From Cocaine Self-Administration.

Authors:  Erin S Calipari; Arthur Godino; Marine Salery; Diane M Damez-Werno; Michael E Cahill; Craig T Werner; Amy M Gancarz; Emily G Peck; Zahra Jlayer; Jacqui Rabkin; Joseph A Landry; Alexander C W Smith; Paola Defilippi; Paul J Kenny; Yasmin L Hurd; Rachael L Neve; David M Dietz; Eric J Nestler
Journal:  J Neurosci       Date:  2019-05-15       Impact factor: 6.167

6.  Cues play a critical role in estrous cycle-dependent enhancement of cocaine reinforcement.

Authors:  Amy R Johnson; Kimberly C Thibeault; Alberto J Lopez; Emily G Peck; L Paul Sands; Christina M Sanders; Munir Gunes Kutlu; Erin S Calipari
Journal:  Neuropsychopharmacology       Date:  2019-01-23       Impact factor: 7.853

7.  Dopamine transporter function fluctuates across sleep/wake state: potential impact for addiction.

Authors:  I P Alonso; J A Pino; S Kortagere; G E Torres; R A España
Journal:  Neuropsychopharmacology       Date:  2020-10-08       Impact factor: 7.853

8.  KOR Control over Addiction Processing: An Exploration of the Mesolimbic Dopamine Pathway.

Authors:  Paige M Estave; Mary B Spodnick; Anushree N Karkhanis
Journal:  Handb Exp Pharmacol       Date:  2022

9.  Roflumilast treatment during forced abstinence reduces relapse to methamphetamine seeking and taking.

Authors:  James J Baek; Hannah Kline; Carmen M Deveau; Bryan K Yamamoto
Journal:  Addict Biol       Date:  2021-08-07       Impact factor: 4.280

10.  Effects of the monoamine stabilizer, (-)-OSU6162, on cocaine-induced locomotion and conditioned place preference in mice.

Authors:  Laila Asth; Lia P Iglesias; Rayssa C Briânis; Anna P Marçal; Nícia P Soares; Daniele C Aguiar; Fabrício A Moreira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-01-20       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.